On 22 June 2021, ImmunoIVD officially joined the European Alliance for Newborn Screening in SMA as a Member Company. View the other Members of the Alliance here. ImmunoIVD is a Swedish company based in Nacka Strand, south of Stockholm, that was founded in 2015 by researchers who wanted to develop a sensitive SCID assay, suitable for usage in routine newborn screening laboratories. In addition, they subsequently developed a screening kit for SCID and SMA.